CD105 or Endoglin or GP160 is a Type I transmembrane protein, which is highly expressed on human vascular endothelial cells. It exists as an Oand N-glycosylated homodimer. Up-regulation of endoglin expression has been demonstrated in tumor vasculature and proliferating cells, suggesting that it is a proliferation-associated endothelial cell marker. CD105 binds to TGF-β1 and Beta3 with high affinity but not TGF-β2. Endoglin is a homodimeric transmembrane glycoprotein highly expressed by endothelial cells. It is a component of the transforming growth factor beta receptor complex as it binds TGFB1 and TGFB3 with high affinity. Endoglin has been shown to be a useful marker to identify tumor angiogenesis. Mutations in the endoglin gene produce hereditary hemorrhagic telangiectasia.
Immunogen
Endoglin antibody was raised against amino acids 26 - 176 of Endoglin (Human).
Key Feature
Clonality
Polyclonal
Host Species
Rabbit
Tested Applications
ELISAIHC
Endoglin antibody can be used in ELISA, and immunohistochemistry starting at 5 μg/mL.: